MUSTANG BIO, INC. Restricted Cash, Noncurrent
MUSTANG BIO, INC. (MBIO) had Restricted Cash, Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2025-03-28
- 2024-12-31: Restricted Cash, Noncurrent $0.00.
- 2024-09-30: Restricted Cash, Noncurrent $375.00K.
- 2024-06-30: Restricted Cash, Noncurrent $375.00K.
- 2024-03-31: Restricted Cash, Noncurrent $375.00K.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-28 |
| 2024-09-30 | $375.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $375.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $375.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $750.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $750.00K 10-Q · filed 2024-11-08 |
| 2023-06-30 | $750.00K 10-Q · filed 2024-08-13 |
| 2023-03-31 | $750.00K 10-Q · filed 2024-05-15 |
| 2022-12-31 | $1.00M 10-K · filed 2024-03-11 |
| 2022-09-30 | $1.00M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $1.00M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $1.00M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.00M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.00M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.00M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.00M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.00M 10-K · filed 2022-03-23 |
| 2020-09-30 | $1.00M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.00M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.00M 10-K · filed 2021-03-24 |
| 2019-09-30 | $500.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $500.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $500.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $500.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $500.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $500.00K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $500.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $500.00K 10-K · filed 2019-03-18 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |